AI assistant
Predictive Oncology Inc. — Director's Dealing 2023
Sep 28, 2023
35106_dirs_2023-09-27_29b5d8d8-28e8-46f4-8c50-0d795148afc5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2023-09-25
Reporting Person: MYERS ROBERT L (CHIEF FINANCIAL OFFICER)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-09-25 | Common Stock | M | 1667 | — | Acquired | 5230 | Direct |
| 2023-09-25 | Common Stock | F | 510 | $2.96 | Disposed | 4720 | Direct |
Footnotes
F1: On September 23, 2020, the Reporting Person was granted 5,000 restricted stock units, vesting in three annual installments on each of September 23, 2021, September 23, 2022 and September 23, 2023.
F2: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock. The shares are delivered to the Reporting Person upon vesting.
F3: 510 shares of common stock withheld by the Company on September 25, 2023 to cover withholding tax, in accordance with Restricted Stock Unit Agreement between Reporting Person and Company.